Cargando…

Efficacy and safety of fondaparinux in preventing venous thromboembolism in Chinese cancer patients: a single-arm, multicenter, retrospective study

OBJECTIVE: Fondaparinux is a synthetic anticoagulant for the prevention of venous thromboembolism (VTE), and its administration in Chinese cancer patients is rarely reported. This study aimed to assess the efficacy and safety of fondaparinux in preventing VTE in Chinese cancer patients. METHODS: A t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Su, Zhong, Xie, Chunying, Li, Ruijun, Pan, Wei, Xu, Lu, Chen, Fei, Cheng, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258345/ https://www.ncbi.nlm.nih.gov/pubmed/37313468 http://dx.doi.org/10.3389/fonc.2023.1165437

Ejemplares similares

Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study
por: Hata, Taishi, et al.
Publicado: (2014)

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux in women at risk after cesarean section
por: Kawaguchi, Ryuji, et al.
Publicado: (2017)

Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery
por: Bergqvist, David
Publicado: (2006)

Fondaparınux Versus Nadroparın for Preventıon of Venous Thromboembolısm After Electıve Hıp and Knee Arthroplasty()
por: Argun, Mahmut, et al.
Publicado: (2013)

Nomogram for Predicting the Postoperative Venous Thromboembolism in Spinal Metastasis Tumor: A Multicenter Retrospective Study
por: Zhang, Hao-ran, et al.
Publicado: (2021)

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP)
por: Dempfle, Carl-Erik, et al.
Publicado: (2021)

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis
por: Dong, Wen-Jun, et al.
Publicado: (2016)

Study on the safety and effectiveness of low-dose vs. regular-dose fondaparinux in preventing venous thromboembolism prophylaxis following total knee arthroplasty
por: Chen, Ping-bo, et al.
Publicado: (2023)

Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux
por: Di Nisio, Marcello, et al.
Publicado: (2013)

Use of Fondaparinux Following Elective Lumbar Spine Surgery Is Associated With a Reduction in Symptomatic Venous Thromboembolism
por: Fourman, Mitchell S., et al.
Publicado: (2019)

Effectiveness of Fondaparinux in the Japanese Population with Acute Venous Thromboembolism -A Study Comparing Patients with and without Cancer-
por: Yamashita, Asami, et al.
Publicado: (2022)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study
por: Fu, Donglin, et al.
Publicado: (2022)

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Occurrence rates and risk factors of in-hospital venous thromboembolism, major bleeding, and death in patients receiving fondaparinux after orthopedic surgery or trauma surgery
por: Ding, Ya, et al.
Publicado: (2023)

Risk of Venous Thromboembolism in Glioblastoma Patients
por: Lim, Gerald, et al.
Publicado: (2018)

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
por: Cornell, Robert Frank, et al.
Publicado: (2019)

Phase 3, single‐arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design
por: Luciani, Matteo, et al.
Publicado: (2018)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making
por: Johnston, Amy, et al.
Publicado: (2018)

Prevention of venous thromboembolism with aspirin following knee surgery: A systematic review and meta-analysis
por: Marrannes, Stephanie, et al.
Publicado: (2021)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Design and Synthesis of Neutralizable Fondaparinux
por: Zhang, Liangwei, et al.
Publicado: (2022)

Venous thromboembolic events in glioblastoma patients: An epidemiological study
por: Eisele, Amanda, et al.
Publicado: (2022)

Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study
por: Huang, Duo, et al.
Publicado: (2019)

Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study
por: Chatzileontiadou, S., et al.
Publicado: (2023)

The Prevention of Venous Thromboembolism After Esophago-Gastric Surgery: A Never-Ending Story
por: Rocco, Raffaele, et al.
Publicado: (2022)

Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007)

Thromboelastographic monitoring of fondaparinux in surgical patients
por: Martinez, B, et al.
Publicado: (2013)

Venous Thromboembolism Rate in Patients With Bladder Cancer According to the Type of Treatment: A Systematic Review
por: Abdullah, Omar, et al.
Publicado: (2022)

Models for predicting venous thromboembolism in ambulatory patients with lung cancer: a systematic review protocol
por: Yan, Ann-Rong, et al.
Publicado: (2021)

Clinical guide SEOM on venous thromboembolism in cancer patients
por: Muñoz Martín, A. J., et al.
Publicado: (2014)

Discovery of protein biomarkers for venous thromboembolism in non-small cell lung cancer patients through data-independent acquisition mass spectrometry
por: Liu, Yanhong, et al.
Publicado: (2023)

Incidence, prevention, risk factors, and prediction of venous thromboembolism in Chinese patients after colorectal cancer surgery: a prospective, multicenter cohort study
por: Wei, Qi, et al.
Publicado: (2023)

Feasibility and safety of rehabilitation after venous thromboembolism
por: Noack, Frank, et al.
Publicado: (2015)

Thromboelastography for the Prevention of Perioperative Venous Thromboembolism in Orthopedics
por: Fan, Dejing, et al.
Publicado: (2022)

Derivation, validation and assessment of a novel nomogram-based risk assessment model for venous thromboembolism in hospitalized patients with lung cancer: A retrospective case control study
por: Li, Huimin, et al.
Publicado: (2022)

Venous Thromboembolism and Adenomyosis: A Retrospective Review
por: Hong, Eliane Yuting, et al.
Publicado: (2020)

Venous thromboembolism in non-COVID-19 population during the pandemic: a nationwide multicenter retrospective survey
por: Qian, Cheng, et al.
Publicado: (2021)

In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9a7b5kbfpk8oncin5knus79k5h